Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2022.0314


Cancer genome and tumor profiling: Promises and challenges in the clinical setting.

Chee-Seng Ku, MD, PhD.


Tumor samples and liquid biopsies for tumor genomic and transcriptomic profiling in conjunction with circulating tumor DNA testing have recently been adopted into the clinical setting to improve decision-making for multi-modal systemic treatment. Whether these cost-effective approaches as compared to whole genome sequencing and RNA sequencing which require expertise, time consuming, and high cost are more realistic to be integrating into routine clinical practice is described in this perspective article.

(Citation: Gastric & Breast Cancer 2022; 17(1): 41-47)

You can have an online full-text access and a PDF of this article:
  • Either purchase this paper for €35 EUR. Please, click here
Please specify DOI of article
  • Or through one year subscription PayPal

Online ISSN : 1109 - 7647
Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 19 January 2022